Jennifer B. Allocco

Jennifer B. Allocco

Auto-generated profile, based on publicly available information

Jennifer B. Allocco

Department of Medicine, Section of Rheumatology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PGPawan K. Gupta
Pawan K. Gupta
JAJennifer B. Allocco
Jennifer B. Allocco
JFJane M. Fraipont
Jane M. Fraipont
MMMichelle L. McKeague
Michelle L. McKeague
PWPeter Wang
Peter Wang
MAMaria-Luisa Alegre
Maria-Luisa Alegre
Limiting CD4+T cell responses is important to prevent solid organ transplant rejection. In a mouse model of costimulation blockade-dependent cardiac allograft tolerance, we previously reported that alloreactive CD4+conventional T cells (Tconvs) develop dysfunction, losing proliferative capacity. In parallel, induction of transplantation tolerance is dependent on the presence of regulatory T cells (Tregs). Whether susceptibility of CD4+Tconvs to Treg suppression is modulated during tolerance induction is unknown. We found that alloreactive Tconvs from transplant tolerant mice had augmented sensitivity to Treg suppression when compared with memory T cells from rejector mice and expressed a transcriptional profile distinct from these memory T cells, including down-regulated expression of the transcription factor Special AT-rich sequence-binding protein 1 (Satb1). Mechanistically, Satb1 deficiency in CD4+T cells limited their expression of CD25 and IL-2, and addition of Tregs, which express higher levels of CD25 than Satb1-deficient Tconvs and successfully competed for IL-2, resulted in greater suppression of Satb1-deficient than wild-type Tconvs in vitro. In vivo, Satb1-deficient Tconvs were more susceptible to Treg suppression, resulting in significantly prolonged skin allograft survival. Overall, our study reveals that transplantation tolerance is associated with Tconvs’ susceptibility to Treg suppression, via modulated expression of Tconv-intrinsic Satb1. Targeting Satb1 in the context of Treg-sparing immunosuppressive therapies might be exploited to improve transplant outcomes.

1 November 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CMChristine M. McIntosh
Christine M. McIntosh
JAJennifer B. Allocco
Jennifer B. Allocco
PWPeter Wang
Peter Wang
MMMichelle L McKeague
Michelle L McKeague
ACAlexandra Cassano
Alexandra Cassano
MAMaria-Luisa Alegre
Maria-Luisa Alegre
Even when successfully induced, immunological tolerance to solid organs remains vulnerable to inflammatory insults, which can trigger rejection. In a mouse model of cardiac allograft tolerance in which infection with Listeria monocytogenes (Lm) precipitates rejection of previously accepted grafts, we showed that recipient CD4+ TCR75 cells reactive to a donor MHC class I–derived peptide become hypofunctional if the allograft is accepted for more than 3 weeks. Paradoxically, infection-induced transplant rejection was not associated with transcriptional or functional reinvigoration of TCR75 cells. We hypothesized that there is heterogeneity in the level of dysfunction of different allospecific T cells, depending on duration of their cognate antigen expression. Unlike CD4+ TCR75 cells, CD4+ TEa cells specific for a peptide derived from donor MHC class II, an alloantigen whose expression declines after transplantation but remains inducible in settings of inflammation, retained function in tolerant mice and expanded during Lm-induced rejection. Repeated injections of alloantigens drove hypofunction in TEa cells and rendered grafts resistant to Lm-dependent rejection. Our results uncover a functional heterogeneity in allospecific T cells of distinct specificities after tolerance induction and reveal a strategy to defunctionalize a greater repertoire of allospecific T cells, thereby mitigating a critical vulnerability of tolerance.

22 January 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMaximiliano Presa
Maximiliano Presa
JRJeremy J. Racine
Jeremy J. Racine
JDJennifer R. Dwyer
Jennifer R. Dwyer
DLDeanna J. Lamont
Deanna J. Lamont
VSVishal Kumar Sarsani
Vishal Kumar Sarsani
DSDavid V. Serreze
David V. Serreze
In both NOD mice and humans, the development of type 1 diabetes (T1D) is dependent in part on autoreactive CD8 + T-cells recognizing pancreatic ß-cell peptides presented by often quite common MHC class I variants. Studies in NOD mice previously revealed the common H2-K d and/or H2-D b class I molecules expressed by this strain acquire an aberrant ability to mediate pathogenic CD8 + T-cell responses through interactions with T1D susceptibility ( Idd ) genes outside the MHC. A gene(s) mapping to the Idd7 locus on proximal Chromosome 7 was previously shown to be an important contributor to the failure of the common class I molecules expressed by NOD mice to mediate the normal thymic negative selection of diabetogenic CD8 + T-cells. Using an inducible model of thymic negative selection and mRNA transcript analyses we initially identified an elevated Nfkbid expression variant is likely an NOD Idd7 region gene contributing to impaired thymic deletion of diabetogenic CD8 + T-cells. CRISPR/Cas9-mediated genetic attenuation of Nfkbid expression in NOD mice resulted in improved negative selection of autoreactive diabetogenic AI4 and NY8.3 CD8 + T-cells. These results indicated allelic variants of Nfkbid represent an Idd7 gene contributing to the efficiency of intrathymic deletion of diabetogenic CD8 + T-cells. However, while enhancing thymic deletion of pathogenic CD8 + T-cells, ablation of Nfkbid expression surprisingly accelerated T1D onset in NOD mice likely at least in part by numerically decreasing regulatory T- and B-lymphocytes (Tregs/Bregs), thereby reducing their peripheral immunosuppressive effects.